Efficacy Assessment of SCENAR Device on Common Spinal Pain Syndrome
NCT ID: NCT03755817
Last Updated: 2021-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2018-11-14
2020-11-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Use of Rechargeable Spinal Cord Stimulators for the Treatment of Neuropathic Pain
NCT05373654
Impact of Peripheral Afferent Input on Central Neuropathic Pain
NCT05646810
Response Profiles to High-concentration Capsaicin Desensitization in Patients with Peripheral Neuropathic Pain with or Without Allodynia: a Regional Multicenter Prospective Cohort
NCT05817591
Effects of Venlafaxine on Chronic Neuropathic Pain Following Spinal Cord Injury
NCT00167856
Comparative Study in Patients With Refractory Chronic Lower Limb Neuropathic Pain and/or Back Neuropathic Pain.
NCT04852107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Scenar application
Application of SCENAR device on
SCENAR application
Active SCENAR application on the painful area
Scenar application with the device off
Application of SCENAR device off
SCENAR application with the device off
Placebo SCENAR application on the painful area
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SCENAR application
Active SCENAR application on the painful area
SCENAR application with the device off
Placebo SCENAR application on the painful area
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Suffering of common spinal pain: cervical pain including cervico-brachial neuralgia, lumbar pain including lumbo-radiculalgia
* Having attended a "pain consultation" or referred to a pain consultant during hospitalization
* Having signed the consent form
* Can be contacted directly by phone if patient is not hospitalized
* Be affiliated to a national insurance scheme or benefiting from such a program
* Pregnant or breast-feeding women
* Patients with a pacemaker
* Patients whose skin condition makes the use of SCENAR impossible (wounds, recent scars, skin infections)
* Patient whose spinal pain is known to be related to inflammatory pathology (spondylarthropathy, rheumatoid arthritis, chondrocalcinosis), trauma (fractures and dislocations), tumor (metastases, myeloma localization), spondylodiscitis infectious, neurological (intrarachidian tumor or posterior fossa) or radiculalgia with deficient signs
* Patients who have already had a SCENAR session
* Patients who have already participated in this study
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Foch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Fischler, MD PhD
Role: STUDY_DIRECTOR
Hopital Foch
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Foch
Suresnes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017015F
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.